Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

In a remarkable case that has stirred fresh conversations about the limits of modern medicine, doctors at Vanderbilt Children’s Hospital in the United States have successfully saved the life of a baby ...